Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NANDROLONE DECANOATE: 98 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
98
Total FAERS Reports
22 (22.4%)
Deaths Reported
53
Hospitalizations
98
As Primary/Secondary Suspect
8
Life-Threatening
3
Disabilities
Aug 30, 2010
FDA Approved
Discontinued
Status
Yes
Generic Available

FDA Application: 013132 ·

First Report: 1997 · Latest Report: 20231107

What Are the Most Common NANDROLONE DECANOATE Side Effects?

#1 Most Reported
Drug abuse
45 reports (45.9%)
#2 Most Reported
Off label use
13 reports (13.3%)
#3 Most Reported
Intentional product misuse
9 reports (9.2%)

All NANDROLONE DECANOATE Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Drug abuse 45 45.9% 15 21
Off label use 13 13.3% 3 8
Hypertension 9 9.2% 4 8
Intentional product misuse 9 9.2% 1 7
Polycythaemia 8 8.2% 4 8
Acne 7 7.1% 4 2
Testicular atrophy 6 6.1% 6 2
Toxic cardiomyopathy 6 6.1% 4 5
Ventricular hypertrophy 6 6.1% 1 6
Acne fulminans 5 5.1% 0 5
Acute kidney injury 5 5.1% 0 3
Cardiomyopathy 5 5.1% 2 4
Hypothalamic pituitary adrenal axis suppression 5 5.1% 3 4
Pulmonary embolism 5 5.1% 4 4
Staphylococcal infection 5 5.1% 0 5
Substance abuse 5 5.1% 1 5
Toxicity to various agents 5 5.1% 5 0

Who Reports NANDROLONE DECANOATE Side Effects? Age & Gender Data

Gender: 7.6% female, 92.4% male. Average age: 36.2 years. Most reports from: CH. View detailed demographics →

Is NANDROLONE DECANOATE Getting Safer? Reports by Year

YearReportsDeathsHosp.
2010 1 1 0
2012 4 1 3
2014 6 0 6
2015 1 0 1
2016 3 0 2
2017 2 0 1
2021 1 0 1
2023 5 4 5

View full timeline →

What Is NANDROLONE DECANOATE Used For?

IndicationReports
Product used for unknown indication 39
Muscle building therapy 15

Official FDA Label for NANDROLONE DECANOATE

Official prescribing information from the FDA-approved drug label.